Home
Company
Therapeutic Focus
Pipeline
UNI-494
Renazorb
Investors
Resources
Contact
Presentations
Investors
Investors
Overview
News
Events & Presentations
IR Calendar
Presentations
Governance
Overview
Management Team
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Financial & Stock Info
Overview
Financial Results
Quote
Charts
Historical Data
Analyst Coverage
Resources
Overview
Contacts
FAQ
Email Alerts
Dec 2, 2024
December 2024 Corporate Presentation
Jun 25, 2024
Oxylanthanum Carbonate (OLC) UNI-OLC-201 Pivotal Trial Topline Data
rss_feed
RSS
Email Alerts
Contacts
RSS News Feed
